333 related articles for article (PubMed ID: 23540719)
1. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
[TBL] [Abstract][Full Text] [Related]
2. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
[TBL] [Abstract][Full Text] [Related]
3. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
4. Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer.
Carus A; Ladekarl M; Hager H; Nedergaard BS; Donskov F
Br J Cancer; 2013 May; 108(10):2116-22. PubMed ID: 23591202
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
[TBL] [Abstract][Full Text] [Related]
7. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
8. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein lipase in non-small cell lung cancer tissue is highly expressed in a subpopulation of tumor-associated macrophages.
Podgornik H; Sok M; Kern I; Marc J; Cerne D
Pathol Res Pract; 2013 Aug; 209(8):516-20. PubMed ID: 23880163
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
[TBL] [Abstract][Full Text] [Related]
12. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
13. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
[TBL] [Abstract][Full Text] [Related]
14. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
15. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
[TBL] [Abstract][Full Text] [Related]
16. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer.
Kobayashi N; Usui S; Kikuchi S; Goto Y; Sakai M; Onizuka M; Sato Y
Lung Cancer; 2012 Feb; 75(2):223-7. PubMed ID: 21764477
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
APMIS; 2010 May; 118(5):371-82. PubMed ID: 20477813
[TBL] [Abstract][Full Text] [Related]
20. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T
Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]